📇 Rhumatologue · PARIS · (75) · Libéral

M YVES LACHKAR

Pourquoi vous devez consulter ce praticien

4 raisons identifiées

Praticien-chercheur
13 articles scientifiques publiés — formation continue solide
Référence presse grand public
Cité 1 fois dans les médias — pédagogie reconnue
Disponibilité géographique
3 lieux d'exercice — choisissez celui qui vous arrange
Délais de RDV courts dans la région
336.2 rhumatos / 100 000 hab. — département bien doté

Rhumatologue

📍 PARIS (75)LibéralRPPS 10000526235

🇫🇷 Publications académiques françaises (7)

✨ Génération du profil synthétique IA en cours…

Publications académiques en France

Articles déposés en accès libre sur l'archive ouverte des universités françaises (HAL) — gage d'activité de recherche en France.

Review of glaucoma management in France
2023
ArticleEuropean Journal of Ophthalmology

Données ANS publiques (Licence Ouverte 2.0) · Enrichissements MonRhumato 100 % opt-in · Toute personne référencée peut demander la suppression ou la rectification.

Top publications · les plus citées

Drug-induced acute angle closure glaucoma

Current opinion in ophthalmology · 2007

📚 150 citations🎯 RCR 5.58Top 7% NIH

Safety and Effectiveness of the PRESERFLO® MicroShunt in Primary Open-Angle Glaucoma: Results from a 2-Year Multicenter Study

Ophthalmology. Glaucoma · 2022

📚 116 citations🎯 RCR 20.85Top 1% NIH🔓 Open Access

Prevalence and risk factors for ocular surface disease among patients treated over the long term for glaucoma or ocular hypertension

European journal of ophthalmology · 2012

📚 95 citations🎯 RCR 4.96Top 8% NIH

Lire l'abstract Crossref ↓

Purpose. To determine the prevalence of ocular surface diseases and identify risk factors in a population of patients receiving antiglaucomatous eyedrops over the long term. Methods. An observational cross-sectional study was designed to investigate ocular surface signs and symptoms using simple clinical tools. An ocular surface disease intensity score was calculated based on 10 questions regarding ocular surface symptoms and signs with a 4-grade scale. Patients were classified into 3 groups (A, B, and C) according to this total score. A multinomial logistic regression was performed in order to identify risk factors for surface disease. Results. In an overall population of 516 patients, 49% belonged to group A, 30% to group B, and 21% to group C. The multivariate analysis showed that the following factors were correlated with the severity of ocular surface disease: patient age, number of daily eyedrops, past topical treatment changes for ocular intolerance (found in the history of 40% of the patients), intraocular pressure (found to be significantly higher in patients with more severe ocular surface disease), and glaucoma severity. Conclusions. Patients treated for primary open-angle glaucoma or ocular hypertension often have ocular surface diseases, more often and more severely in older patients receiving more drugs and presenting with more severe glaucoma. These high prevalence values might therefore have consequences on the burden of the disease in terms of adherence to treatment and quality of life.

Cookies & analyse de trafic

M YVES LACHKAR

Pourquoi vous devez consulter ce praticien

Publications académiques en France

Lieux de consultation(3)

Tarifs & secteur de conventionnement

Prendre rendez-vous & contact

Articles de presse (1)

Top publications · les plus citées

Publications scientifiques (13) — classées par pathologie

Transversal6

Revue générale3

Pharmacovigilance2

Vraie vie / RWE2

Épidémiologie & registres1

Revue / méta-analyse1

Datasets & protocoles partagés

Partager cette fiche